Figure 1.
A dual-chamber pacemaker woth ventricular lead implanted close to right
Table 1.
Selected laboratory findings trought patirnt’s hospitalisation
| Emergency department (No. of days: 1) | |||
|---|---|---|---|
| Test | Result | Range | |
| BUN | 11.6 mg/dl | 9.0-22.0 | |
| CRP | 3.0 | 0.00-5.00 | |
| NT-pro BNP | 4069.0 pg/ml H | <125 | |
| Troponin T | 47.4 ng/l H | <14.0 | |
| Cardiological ward (No. of days 21) | |||
| BUN | Day 2 Day 3 Day 12 | 12.1 mg/dl 15.0 mg/dl 8.7 mg/dl L | 9.0-22.0 |
| CRP | Day 2 Day 3 Day 4 Day 12 | 36.8 mg/l H 31.7 mg/l H 2.1. mg/l 46.9 mg/l H | 0.00-5.00 |
| Creatinine | Day 2 Day 3 Day 4 Day 12 | 0.59 mg/dl 0.68 mg/dl 0.93 mg/dl 0.48 mg/dl | 0.40-1.20 |
| Nt-pro BNP | Day 3 Day 20 | 12155.0 pg/ml H 422.0 pg/ml H | <125 |
| PCR | Day 2 Day 3 Day 4 Day 12 | 0.42 ng/ml 0.42 ng/ml 0,04 ng/ml 0,08 ng/ml | <0.5 ng/ml - low risk of sepsis >2.0 ng/ml - high risk of sepsis |
| Neurological ward (No. days 6) | |||
| BUN | Day 2 Day 6 | 13.1 mg/dl 17.3 mg/dl | 9.0-22.0 |
| CRP | Day 2 Day 6 | 96.3 mg/l H 133.8 mg/l H | 0.00-5.00 |
| Creatinine | Day 2 Day 6 | 0.60 mg/dl 0.69 mg/dl | 0.40-1.20 |
| Neurological rehabilitation ward (No. days 29) | |||
| BUN | Day 2 Day 12 Day 25 | 11.3 mg/dl 10.0 mg/dl 16.4 mg/dl | 9.0-22.0 |
| CRP | Day 2 Day 12 Day 25 | 45.9 mg/dl H 36.2 mg/dl H 1.9 mg/dl | 0.00-5.00 |
| Creatinine | Day 2 Day 12 Day 25 | 0.55 mg/dl 0.52 mg/dl 0.50 mg/dl | 0.40-1.20 |
| BUN-Blood urea nitrogen, CRP-C-reactive protein, PCR - Procalcitonin | |||
Table 2.
Medications administered during patient’s stay
| Ward | Medications |
|---|---|
| ED | Isotonic solution i.v. 500 ml |
| Cardiological ward | Cefazolin i.v. 1g, Enoxaparin s.c. 80mg/0.8ml, Glucose 5% i.v. 50 mg/ml, Hydroxyzine in tab. 25 mg, Insulinum humanum s.c. 100 U/I, Insulinum humanum isophanum s.c. 100 U/I, IPP in Tab. 20 mg, Ketoprofen i.v. 50 mg/ml, Lidocaine 1% i.v., Lorazepam in tab. 1 mg, Zolpidem tartrate in tab. 10 mg, Hialuronic isotonic inhalation solution, Iohexol i.v. 647 mg/ml (0.3 g of iodine), Non-adhesive foam dressing with Hydrofiber® technology and silver on sacrum, Isotonic solution i.v. 500ml, Paracetamol i.v. 10 mg/ml, Paracetamol in tab. 500 mg, Ramipril in tab. 5 mg, Pantoprazole i.v. 40 mg, Paracetamol and Tramadol in tab. 37.5 mg +325 mg, Torasemide in tab. 10 mg, Torasemide in tab. 5 mg, Torasemide i.v. 5mg/ml |
| Neurological ward | Ceftriaxone i.v. 2g, Enoxaparin s.c. 40 mg, Estazolam TZF in Tab. 2 mg, Insulinum humanum s.c. 100 U/I, Insulinum humanum isophanum s.c. 100 U/I, IPP in tab. 20 mg, Lactobacillus in caps., Levothyroxine sodium in tab. 100 mcg, Non-adhesive foam dressing with Hydrofiber® technology, Adhesive foam dressing with silicone contact layer, Hydrophilic polymer foam dressing, Torasemide in tab. 5 mg |
| Neurological rehabilitation ward | Ceftriaxone i.v. 2g, Enoxaparin s.c. 40 mg, Furazidin in tab. 20 mg, IPP in tab. 20 mg, Potassium in tab. 391 mg K+, Lactobacillus., Levothyroxine sodium in tab. 50 mg, Natrium chloratum 0.9% i.v., 100 ml, Insulin aspart+- Insulin aspart protamine suspension s.c. 100 U/I, Torasemide in tab. 5 mg |
| caps. – capsules; ED - Emergency Department; g – gram; i.m. – intramuscular; i.v. – intravenous; IPP – proton pump inhibitor; IU / JM – international units; mcg – microgram; mg – milligram; ml – milliliter; s.c. – subcutaneous; tab. – tablet; U/I – units of insulin. | |